Sign in to view content

Episode 10: Cytokines Levels and Response to Ranibizumab in DME with Dr. Rajeev Muni

Keyvan Koushan, MD, FRCSC

Audio
Published 2018

Related

Baseline Characteristics of Patients Who Did or Did Not Maintain 12-Week and 16-Week Aflibercept 8 mg Dosing Intervals in the Phase 2/3 PHOTON Trial
Eric W Schneider, MD
Annual Meeting Talks
2023
Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials
Katherine E Talcott, MD
Annual Meeting Talks
2021
Episode 204: Journal Club Featuring AMD Cost Analysis, DME Real-World Trends, PVDs and Retinal Breaks
Jayanth Sridhar, MD
Member Podcasts
2019

Category: Diabetic Retinopathy

See more